Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SpagoPix (SN132D) in suspected endometriosis
NCT05664828Phase 2Completed
- Sponsor
- Spago Nanomedical AB
- Start
- Nov 2022
- Primary completion
- Jun 2023
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pegfosimer manganese in endometriosis, sponsored by Spago Nanomedical AB. Started Nov 2022; status: completed.
02
Drugs
pegfosimer manganese
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT05664828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664828.